Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.
Latest website image capture
Clouds background image

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T16:25:56.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about replacing “Artificial Intelligence” with “Super Intelligence” in federal agency content.
    Difference
    1%
    Check dated 2026-10-26T16:17:24.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T16:32:59.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from `v3.7.0` to `v3.7.1` on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T16:28:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous detailed study record content with a minimal access-restricted screen.
    Difference
    18%
    Check dated 2026-09-21T21:00:08.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This is a metadata update indicating the page version rather than any substantive content change.
    Difference
    0.0%
    Check dated 2026-08-31T17:16:26.000Z thumbnail image

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.